Information  X 
Enter a valid email address

Accrol Group Hldgs (ACRL)

  Print      Mail a friend

Thursday 31 May, 2018

Accrol Group Hldgs

Result of General Meeting

RNS Number : 8593P
Accrol Group Holdings PLC
31 May 2018

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

31 May 2018




Result of General Meeting


Accrol Group Holdings plc, the leading independent tissue converter in the UK, announces that, at its general meeting held earlier today (the "General Meeting"), all resolutions were approved. Following the approval of these resolutions, the placing to raise £8.0 million (before expenses) described in the announcement dated 15 May 2018 titled "Proposed Placing to raise £8 million" (the "Placing") remains conditional only on admission of the new ordinary shares being issued pursuant to the Placing, which is expected to occur at 8am on Friday 1 June 2018. 


The resolutions approved today include those which relate to the open offer described in the announcement dated 22 May 2018 titled "Open Offer". The result of the Open Offer is expected to be announced on 7 June 2018.



Zeus Capital Limited (Nominated Adviser & Broker)


Dan Bate / Andrew Jones                                                                  

Tel: +44 (0) 161 831 1512

Dominic King / John Goold                                                                     

Tel: +44 (0) 203 829 5000



Belvedere Communications Limited                                          


Cat Valentine

Mob: +44 (0) 7715 769 078


Notes to Editors


Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to major retailers throughout the UK. 


Accrol operates from three sites:


·      A manufacturing, storage and distribution facility in Blackburn;

·      A facial tissue plant, also in Blackburn; and

·      A manufacturing, storage and distribution facility in Leyland.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t